Monday, 31 August 2026European Markets

CLOUDBERRY CLEAN Stock Jumps By 32% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of CLOUDBERRY CLEAN (Oslo Børs Benchmark Index_GI: CLOUD.OL) jumped by a staggering 32% in 21 sessions from kr10.5 to kr13.86 at 14:25 EST on Monday, after three successive sessions in a row of gains. Oslo Børs Benchmark Index_GI is dropping 0.32% to kr1,227.59, after three sequential sessions in a row of gains.

About CLOUDBERRY CLEAN

Cloudberry Clean Energy ASA operates as a renewable energy company. It operates through four segments: Production, Development, Operations and Corporate. The company engages in the ownership, development, and operation of hydropower plants and wind farms in Norway, Sweden, and Denmark. Cloudberry Clean Energy ASA was incorporated in 2017 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, CLOUDBERRY CLEAN has a trailing twelve months EPS of kr0.92.

PE Ratio

CLOUDBERRY CLEAN has a trailing twelve months price to earnings ratio of 15.07. Meaning, the purchaser of the share is investing kr15.07 for every norwegian krone of annual earnings.

Volume

Today's last reported volume for CLOUDBERRY CLEAN is 361817 which is 63.24% below its average volume of 274373.

More news about CLOUDBERRY CLEAN (CLOUD.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com